Substance / Medication

Insulin aspart

Overview

Active Ingredient
insulin aspart, human
RxNorm CUI
51428

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

948 trials linked to this intervention

948
Total Trials
110
Recruiting
300
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.
Wojciechowski Piotr, Niemczyk-Szechowska Patrycja, Olewińska Elżbieta et al. · Pol Arch Med Wewn · 2015
PMID: 25644227Meta-Analysis
Meta-analysis of insulin aspart versus regular human insulin used in a basal-bolus regimen for the treatment of diabetes mellitus.
Heller Simon, Bode Bruce, Kozlovski Plamen et al. · J Diabetes · 2013
PMID: 23586846Meta-AnalysisFull text (PMC)
Comparing Postprandial Glycemic Control Using Fiasp vs Insulin Aspart in Hospitalized Patients With Type 2 Diabetes.
Alexanian Sara M, Cheney Michael C, Spartano Nicole L et al. · Endocr Pract · 2025
PMID: 39643003RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Insulin aspart (substance)
SNOMED CT
325072002
UMLS CUI
C0123677
RxNorm CUI
51428

Clinical Data

This intervention maps to 13 entities in the Ltrl knowledge graph.

4
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
948
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Insulin aspart — Conditions, Biomarkers & Specialists | Ltrl | Ltrl